BiotechTube
Home/Orthogon Therapeutics/Ali H. Munawar, Ph.D.
AH

Ali H. Munawar, Ph.D.

Chief Executive Officer & Founder

Orthogon Therapeutics

Therapeutic Areas

Infectious DiseaseOncology

Orthogon Therapeutics Pipeline

DrugIndicationPhase
Anti-polyomavirus programBK virus infection (e.g., nephropathy in transplant patients)Preclinical

Leadership Team at Orthogon Therapeutics

MR
Mark R. Spyvee, D. Phil.
Vice President, Medicinal Chemistry
SW
Stephen Weeks, Ph.D.
Director, Structural Biology & Biophysics
View full Orthogon Therapeutics profile